Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 7
Submit an article Journal homepage
6,375
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure

Nicholas Hobart-Portera Department of Pediatrics, Division of Pediatric Emergency Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USAView further author information
,
Michal Steinb Department of Medical Affairs, Kamada Ltd., Beit Kama, IsraelView further author information
,
Naveh Tohb Department of Medical Affairs, Kamada Ltd., Beit Kama, IsraelView further author information
,
Novinyo Amegac Department of Medical Affairs, Kedrion Biopharma Inc., Fort Lee, NJ, USAView further author information
,
Huy-Binh Nguyenc Department of Medical Affairs, Kedrion Biopharma Inc., Fort Lee, NJ, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0842-1796View further author information
ORCID Icon &
James Linakisd Departments of Emergency Medicine and Pediatrics, The Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, USAView further author information
Pages 2090-2096 | Received 28 Sep 2020, Accepted 16 Nov 2020, Published online: 09 Feb 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Sylvie Pichon, Francoise Guinet-Morlot, Jamshid Saleh, Brandon Essink, Andrea-Clemencia Pineda-Peña, Annick Moureau, Celine Petit & Ada-Maria Minutello. (2023) Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults. Human Vaccines & Immunotherapeutics 19:3.
Read now
Ruifeng Chen, Hu Li, Wuyang Zhu, Hongbin Cheng, Yu Li, Xiaomei Li, Faliang Li, Xiaoqiang Liu, Shixiong Hu, Baigang Yan, Yishan Zheng, Yongbo Zuo, Guanmu Dong & Xiangming Li. (2023) Expert consensus on the clinical application of ormutivimab injection for use against the rabies virus. Expert Opinion on Drug Safety 0:0, pages 1-8.
Read now
Ravish S. Haradanhalli, Nidhi Fotedar, Nitu Kumari & D. H. Ashwath Narayana. (2022) Safety and clinical efficacy of human rabies immunoglobulin in post exposure prophylaxis for category III animal exposures. Human Vaccines & Immunotherapeutics 18:5.
Read now
Jerry Siegel & Karl Kappeler. (2022) Commentary on the implications of safety and efficacy studies in pediatric patients with administration of human rabies immune globulin (HRIG)?. Human Vaccines & Immunotherapeutics 18:5.
Read now

Articles from other publishers (5)

Ravish S. Haradanhalli, Nitu Kumari, Mysore K. Sudarshan, D. H. Ashwath Narayana, Ramya M. Prashanth & Jithin Surendran. (2022) Defining the volume of rabies immunoglobulins/ rabies monoclonal antibodies requirement for wound infiltration of category III animal exposures – an exploratory study. Human Vaccines & Immunotherapeutics 17:12, pages 5355-5360.
Crossref
Sylvie Pichon, Annick Moureau, Celine Petit, Judith L. Kirstein, Eric Sheldon, Francoise Guinet-Morlot & Ada-Maria Minutello. (2023) Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults. Vaccine.
Crossref
Monir Ejemel, Todd G. Smith, Lauren Greenberg, William C. Carson, David Lowe, Yong Yang, Felix R. Jackson, Clint N. Morgan, Brock E. Martin, Chantal Kling, Christina L. Hutson, Nadia Gallardo-Romero, James A. Ellison, Susan Moore, Adam Buzby, John Sullivan-Bolyai, Mark Klempner & Yang Wang. (2022) A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis. Scientific Reports 12:1.
Crossref
Marie-Clotilde Bernard, Florence Boudet, Andrea-Clemencia Pineda-Peña & Françoise Guinet-Morlot. (2022) Inhibitory effect of concomitantly administered rabies immunoglobulins on the immunogenicity of commercial and candidate human rabies vaccines in hamsters. Scientific Reports 12:1.
Crossref
Rita V Burke, Pierantonio Russo, Michael Sicilia, William Wolowich, Novinyo Amega & Huy-Binh Nguyen. (2022) Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study. BMJ Open 12:4, pages e055411.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.